Connective tissue growth factor reacts as an IL - World Journal of ...
Connective tissue growth factor reacts as an IL - World Journal of ...
Connective tissue growth factor reacts as an IL - World Journal of ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
TR, Gao YT. Hepatitis B <strong>an</strong>d C virus infection <strong>an</strong>d the risk <strong>of</strong><br />
biliary tract c<strong>an</strong>cer: a population-b<strong>as</strong>ed study in China. Int J<br />
C<strong>an</strong>cer 2008; 122: 1849-1853<br />
11 Ahrendt SA, Nakeeb A, Pitt HA. Chol<strong>an</strong>giocarcinoma. Clin<br />
Liver Dis 2001; 5: 191-218<br />
12 Chen RF, Li ZH, Zou SQ, Chen JS. Effect <strong>of</strong> hepatitis C virus<br />
core protein on modulation <strong>of</strong> cellular proliferation <strong>an</strong>d<br />
apoptosis in hilar chol<strong>an</strong>giocarcinoma. Hepatobiliary P<strong>an</strong>creat<br />
Dis Int 2005; 4: 71-74<br />
13 Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea<br />
F, Martelli C, Savio A, Trevisi P, Nardi G. Intrahepatic chol<strong>an</strong>giocarcinoma<br />
<strong>an</strong>d hepatitis C <strong>an</strong>d B virus infection, alcohol<br />
intake, <strong>an</strong>d hepatolithi<strong>as</strong>is: a c<strong>as</strong>e-control study in Italy. C<strong>an</strong>cer<br />
Causes Control 2001; 12: 959-964<br />
14 Kobay<strong>as</strong>hi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki<br />
Y, Ar<strong>as</strong>e Y, Mur<strong>as</strong>hima N, Chayama K, Kumada H. Incidence<br />
<strong>of</strong> primary chol<strong>an</strong>giocellular carcinoma <strong>of</strong> the liver in jap<strong>an</strong>ese<br />
patients with hepatitis C virus-related cirrhosis. C<strong>an</strong>cer 2000;<br />
88: 2471-2477<br />
15 Perumal V, W<strong>an</strong>g J, Thuluvath P, Choti M, Torbenson M.<br />
Hepatitis C <strong>an</strong>d hepatitis B nucleic acids are present in intrahepatic<br />
chol<strong>an</strong>giocarcinom<strong>as</strong> from the United States. Hum Pathol<br />
2006; 37: 1211-1216<br />
16 Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S,<br />
Lee SK, Seo DW, Kim MH, Suh DJ. Hepatitis B virus infection<br />
<strong>an</strong>d intrahepatic chol<strong>an</strong>giocarcinoma in Korea: a c<strong>as</strong>e-control<br />
study. Am J G<strong>as</strong>troenterol 2008; 103: 1716-1720<br />
17 Akai PS, Pungpak S, Chaicumpa W, Viroj K, Bunnag D, Befus<br />
AD. Serum <strong>an</strong>tibody response to Opisthorchis viverrini<br />
<strong>an</strong>tigen <strong>as</strong> a marker for opisthorchi<strong>as</strong>is-<strong>as</strong>sociated chol<strong>an</strong>giocarcinoma.<br />
Tr<strong>an</strong>s R Soc Trop Med Hyg 1994; 88: 471-474<br />
18 Wat<strong>an</strong>apa P, Wat<strong>an</strong>apa WB. Liver fluke-<strong>as</strong>sociated chol<strong>an</strong>giocarcinoma.<br />
Br J Surg 2002; 89: 962-970<br />
19 Andoh H, Y<strong>as</strong>ui O, Kurokawa T, Sato T. Chol<strong>an</strong>giocarcinoma<br />
coincident with schistosomi<strong>as</strong>is japonica. J G<strong>as</strong>troenterol 2004;<br />
39: 64-68<br />
20 W<strong>an</strong>i NA, Chrungoo RK. Biliary <strong>as</strong>cari<strong>as</strong>is: surgical <strong>as</strong>pects.<br />
<strong>World</strong> J Surg 1992; 16: 976-979<br />
21 Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, Choi DW,<br />
J<strong>an</strong>g KT, Lee NY, Kim S, Hong ST. Gallstones <strong>an</strong>d Clonorchis<br />
sinensis infection: a hospital-b<strong>as</strong>ed c<strong>as</strong>e-control study in Korea.<br />
J G<strong>as</strong>troenterol Hepatol 2008; 23: e399-e404<br />
22 Kurathong S, Lerdver<strong>as</strong>irikul P, Wongpaitoon V, Pramoolsinsap<br />
C, K<strong>an</strong>j<strong>an</strong>apitak A, Varavithya W, Phuapradit P,<br />
Bunyaratvej S, Upatham ES, Brockelm<strong>an</strong> WY. Opisthorchis<br />
viverrini infection <strong>an</strong>d chol<strong>an</strong>giocarcinoma. A prospective,<br />
c<strong>as</strong>e-controlled study. G<strong>as</strong>troenterology 1985; 89: 151-156<br />
23 Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, J<strong>an</strong>g KT,<br />
Lee NY, Kim S, Hong ST. Chol<strong>an</strong>giocarcinoma <strong>an</strong>d Clonorchis<br />
sinensis infection: a c<strong>as</strong>e-control study in Korea. J Hepatol<br />
2006; 44: 1066-1073<br />
24 Iida F, Iida R, Kamijo H, Tak<strong>as</strong>o K, Miyazaki Y, Funab<strong>as</strong>hi W,<br />
Tsuchiya K, Matsumoto Y. Chronic Jap<strong>an</strong>ese schistosomi<strong>as</strong>is<br />
<strong>an</strong>d hepatocellular carcinoma: ten years <strong>of</strong> follow-up in Yam<strong>an</strong><strong>as</strong>hi<br />
Prefecture, Jap<strong>an</strong>. Bull <strong>World</strong> Health Org<strong>an</strong> 1999; 77:<br />
573-581<br />
25 Matsuda M, Fujii H. Chronic schistosomi<strong>as</strong>is japonica is <strong>an</strong><br />
WJG|www.wjgnet.com<br />
Cai WK et al . Risk <strong>factor</strong>s for HC<br />
independent adverse prognostic <strong>factor</strong> for survival in hepatocellular<br />
carcinoma patients who have undergone hepatic<br />
resection: clinicopathological <strong>an</strong>d prognostic <strong>an</strong>alysis <strong>of</strong> 198<br />
consecutive patients. <strong>World</strong> J Surg 2009; 33: 2644-2650<br />
26 Abdel-Rahim AY. Par<strong>as</strong>itic infections <strong>an</strong>d hepatic neopl<strong>as</strong>ia.<br />
Dig Dis 2001; 19: 288-291<br />
27 H<strong>as</strong>well-Elkins MR, Sithithaworn P, Mairi<strong>an</strong>g E, Elkins DB,<br />
Wongrat<strong>an</strong>acheewin S, Kaewkes S, Mairi<strong>an</strong>g P. Immune responsiveness<br />
<strong>an</strong>d par<strong>as</strong>ite-specific <strong>an</strong>tibody levels in hum<strong>an</strong><br />
hepatobiliary dise<strong>as</strong>e <strong>as</strong>sociated with Opisthorchis viverrini<br />
infection. Clin Exp Immunol 1991; 84: 213-218<br />
28 Satarug S, H<strong>as</strong>well-Elkins MR, Tsuda M, Mairi<strong>an</strong>g P, Sithithaworn<br />
P, Mairi<strong>an</strong>g E, Esumi H, Sukpr<strong>as</strong>ert S, Yongv<strong>an</strong>it<br />
P, Elkins DB. Thiocy<strong>an</strong>ate-independent nitrosation in<br />
hum<strong>an</strong>s with carcinogenic par<strong>as</strong>ite infection. Carcinogenesis<br />
1996; 17: 1075-1081<br />
29 Thamavit W, Pairojkul C, Tiwawech D, Shirai T, Ito N.<br />
Strong promoting effect <strong>of</strong> Opisthorchis viverrini infection on<br />
dimethylnitrosamine-initiated hamster liver. C<strong>an</strong>cer Lett 1994;<br />
78: 121-125<br />
30 Satarug S, L<strong>an</strong>g MA, Yongv<strong>an</strong>it P, Sithithaworn P, Mairi<strong>an</strong>g<br />
E, Mairi<strong>an</strong>g P, Pelkonen P, Bartsch H, H<strong>as</strong>well-Elkins MR.<br />
Induction <strong>of</strong> cytochrome P450 2A6 expression in hum<strong>an</strong>s by<br />
the carcinogenic par<strong>as</strong>ite infection, opisthorchi<strong>as</strong>is viverrini.<br />
C<strong>an</strong>cer Epidemiol Biomarkers Prev 1996; 5: 795-800<br />
31 Jarnagin W, Winston C. Hilar chol<strong>an</strong>giocarcinoma: diagnosis<br />
<strong>an</strong>d staging. HPB (Oxford) 2005; 7: 244-251<br />
32 Yachimski P, Pratt DS. Chol<strong>an</strong>giocarcinoma: natural history,<br />
treatment, <strong>an</strong>d strategies for surveill<strong>an</strong>ce in high-risk patients.<br />
J Clin G<strong>as</strong>troenterol 2008; 42: 178-190<br />
33 Wiesner RH, LaRusso NF. Clinicopathologic features <strong>of</strong> the<br />
syndrome <strong>of</strong> primary sclerosing chol<strong>an</strong>gitis. G<strong>as</strong>troenterology<br />
1980; 79: 200-206<br />
34 Broomé U, Olsson R, Lööf L, Bodemar G, Hultcr<strong>an</strong>tz R, D<strong>an</strong>ielsson<br />
A, Prytz H, S<strong>an</strong>dberg-Gertzén H, Wallerstedt S, Lindberg<br />
G. Natural history <strong>an</strong>d prognostic <strong>factor</strong>s in 305 Swedish<br />
patients with primary sclerosing chol<strong>an</strong>gitis. Gut 1996; 38:<br />
610-615<br />
35 Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolm<strong>an</strong>nskog<br />
F. Risk <strong>factor</strong>s in primary sclerosing chol<strong>an</strong>gitis. J<br />
Hepatol 1994; 21: 1061-1066<br />
36 Burak K, Angulo P, P<strong>as</strong>ha TM, Eg<strong>an</strong> K, Petz J, Lindor KD.<br />
Incidence <strong>an</strong>d risk <strong>factor</strong>s for chol<strong>an</strong>giocarcinoma in primary<br />
sclerosing chol<strong>an</strong>gitis. Am J G<strong>as</strong>troenterol 2004; 99: 523-526<br />
37 Parker RG, Kendall EJ. The liver in ulcerative colitis. Br Med J<br />
1954; 2: 1030-1032<br />
38 Converse CF, Reag<strong>an</strong> JW, DeCosse JJ. Ulcerative colitis <strong>an</strong>d<br />
carcinoma <strong>of</strong> the bile ducts. Am J Surg 1971; 121: 39-45<br />
39 Weismüller TJ, Wedemeyer J, Kubicka S, Str<strong>as</strong>sburg CP,<br />
M<strong>an</strong>ns MP. The challenges in primary sclerosing chol<strong>an</strong>gitis-<br />
-aetiopathogenesis, autoimmunity, m<strong>an</strong>agement <strong>an</strong>d malign<strong>an</strong>cy.<br />
J Hepatol 2008; 48 Suppl 1: S38-S57<br />
40 Chal<strong>as</strong><strong>an</strong>i N, Baluyut A, Ismail A, Zam<strong>an</strong> A, Sood G, Ghalib<br />
R, McC<strong>as</strong>hl<strong>an</strong>d TM, Reddy KR, Zervos X, Anbari MA, Hoen<br />
H. Chol<strong>an</strong>giocarcinoma in patients with primary sclerosing<br />
chol<strong>an</strong>gitis: a multicenter c<strong>as</strong>e-control study. Hepatology 2000;<br />
31: 7-11<br />
S- Editor Sun H L- Editor W<strong>an</strong>g XL E- Editor Zheng XM<br />
253 J<strong>an</strong>uary 14, 2011|Volume 17|Issue 2|
Change language